The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
809
January 12, 1990
View Complete Issue         Table of Contents 2019 
Surfactant for Premature Infants With Respiratory Distress
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Surfactant for Premature Infants With Respiratory Distress
January 12, 1990 (Issue: 809)
The US Food and Drug Administration recently approved ''Treatment IND';'; (investigational new drug) protocols for Exosurf (Burroughs Wellcome) and Survanta (Ross), two preparations of surfactant used for prevention and treatment of the respiratory...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Surfactant for Premature Infants With Respiratory Distress
Article code: 809b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.